ARCHIVES

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

This article is from The Cancer Letter archive.

Vol. 21 No. 25 | June 23, 1995

Download PDF Visit The Full Archive

Related Articles

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001

Eight Win ASCO Young Investigator Awards

August 22, 1986

Search for New NCI director focuses On California; Possibilities Include Korn, Beahrs, Gale, Others

September 23, 1988

In congress: Scientists Seek Closing NIH Office Of Alternative Medicine

July 11, 1997

EU Gives Marketing Approval For HBV Sequencing Test

April 29, 2011

NCI advisory panel recommends funding a 10-year Human Cancer Genome Project with $1.35 billion in new money.

March 18, 2005